Rha SY, Castanon E, Gill S, Senellart H, et al. Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort. Cancer 2025;131:e70015.
PMID: 40808295